AXE 1.92% 26.5¢ archer materials limited

Ann: Biochip experiments begin to develop kidney disease testing, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,307 Posts.
    lightbulb Created with Sketch. 455
    great response, thanks. I hope your knowledge isn't from a personal experience. In regard to the clinical trials part, if we are in a position to start clinical trials, then the SP will be way north of here. that will involve collaborations / partnerships with big pharma or hospitals. This news alone would be huge.
    Last edited by HongKongPhooey: 27/08/24
 
watchlist Created with Sketch. Add AXE (ASX) to my watchlist
(20min delay)
Last
26.5¢
Change
0.005(1.92%)
Mkt cap ! $67.53M
Open High Low Value Volume
26.5¢ 27.0¢ 26.0¢ $29.40K 111.0K

Buyers (Bids)

No. Vol. Price($)
2 5962 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 40677 2
View Market Depth
Last trade - 15.25pm 05/11/2024 (20 minute delay) ?
AXE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.